1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Cost-effectiveness Analysis: new trials by email Literature Review of Cost-effectiveness Analysis trials Research Report on Cost-effectiveness Analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer Long-acting granulocyte colony stimulating factor, Short-acting granulocyte colony stimulating factor - Chemotherapy-induced Neutropenia, Febrile Neutropenia, Drug-Induced | Phase 3 | Unknown | Lei Li | 200 | 2019-10-01 | 2019-10-08 |
Carcinoma, Ovarian Epithelial (1) · Chemotherapy-Induced Febrile Neutropenia (1)
Adnexal Diseases (1) · Agranulocytosis (1) · Carcinoma (1) · Cytopenia (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Febrile Neutropenia (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Lei Li (1)
China (1)
Lei Li, M.D. (1)